173 related articles for article (PubMed ID: 31762818)
41. BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia.
Zhou JD; Zhang TJ; Xu ZJ; Gu Y; Ma JC; Li XX; Guo H; Wen XM; Zhang W; Yang L; Liu XH; Lin J; Qian J
Diagn Pathol; 2019 Jun; 14(1):68. PubMed ID: 31253168
[TBL] [Abstract][Full Text] [Related]
42. [Effects of pre-transplant course on prognosis of allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia].
Liu XJ; Huang XJ; Xu LP; Liu KY; Zhang XH; Yan CH; Wang Y
Zhonghua Xue Ye Xue Za Zhi; 2019 Mar; 40(3):182-186. PubMed ID: 30929382
[No Abstract] [Full Text] [Related]
43. Prognostic role of SCAMP family in acute myeloid leukemia.
Qian T; Cheng Z; Quan L; Zeng T; Cui L; Liu Y; Si C; Huang W; Dai Y; Chen J; Liu L; Jiao Y; Deng C; Pang Y; Ye X; Shi J; Fu L
Pharmacogenomics J; 2020 Aug; 20(4):595-600. PubMed ID: 31988488
[TBL] [Abstract][Full Text] [Related]
44. [The effect of WT1 expression on the prognosis of allogeneic hematopoietic stem cell transplantation in acute leukemia].
Jiang BQ; Luo Y; Zhao YM; Tan YM; Yu J; Lai XY; Zhu YY; Sun J; Zheng WY; He JS; Wei GQ; Cai Z; Huang H; Shi JM
Zhonghua Xue Ye Xue Za Zhi; 2018 Dec; 39(12):989-993. PubMed ID: 30612399
[No Abstract] [Full Text] [Related]
45. [Clinical analysis on adult acute T-lymphoblastic leukemia].
Zhang Q; Zhou CL; Fu MW; Wang JY; Lin D; Liu BC; Li W; Mi YC; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):478-82. PubMed ID: 22541122
[TBL] [Abstract][Full Text] [Related]
46. [Effect of consolidation before allogeneic hematopoietic stem cell transplantation for non-favorable acute myeloid leukemia patients with first complete remisson and negative minimal residual disease].
Zhang YM; Zhang Y; Ni X; Gao L; Qiu HY; Zhang YS; Tang GS; Chen J; Zhang WP; Wang JM; Yang JM; Hu XX
Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):16-22. PubMed ID: 32023749
[No Abstract] [Full Text] [Related]
47. Prognostic role of ACTL10 in Cytogenetic Normal Acute Myeloid Leukemia.
Lai R; Zhang W; He X; Liao X; Liu X; Fu W; Yang P; Wang J; Hu K; Yuan X; Zhang X; Jing H; Liu W
J Cancer; 2020; 11(17):5150-5161. PubMed ID: 32742462
[TBL] [Abstract][Full Text] [Related]
48. High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
Candoni A; De Marchi F; Zannier ME; Lazzarotto D; Filì C; Dubbini MV; Rabassi N; Toffoletti E; Lau BW; Fanin R
Leuk Res; 2017 Dec; 63():22-27. PubMed ID: 29096332
[TBL] [Abstract][Full Text] [Related]
49. High expression of microRNA-500 is associated with poor prognosis in patients with acute myeloid leukemia receiving allogeneic hematopoietic stem cell transplantation.
Zhang G; Shi J; Yang X; Zhang X; Zhang L; Zhang J; Yang S; Wang J; Hu K; Ke X; Fu L
Oncol Lett; 2019 Jun; 17(6):5815-5820. PubMed ID: 31186809
[TBL] [Abstract][Full Text] [Related]
50. Retrospective analysis of children with high-risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML-05 clinical trial.
Hyakuna N; Hashii Y; Ishida H; Umeda K; Takahashi Y; Nagasawa M; Yabe H; Nakazawa Y; Koh K; Goto H; Fujisaki H; Matsumoto K; Kakuda H; Yano M; Tawa A; Tomizawa D; Taga T; Adachi S; Kato K
Pediatr Blood Cancer; 2019 Oct; 66(10):e27875. PubMed ID: 31309713
[TBL] [Abstract][Full Text] [Related]
51. Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study.
Grosicki S; Holowiecki J; Kuliczkowski K; Skotnicki A; Hellmann A; Kyrcz-Krzemien S; Dmoszynska A; Sułek K; Kloczko J; Jedrzejczak WW; Warzocha K; Zdziarska B; Wierzbowska A; Pluta A; Komarnicki M; Giebel S
Am J Hematol; 2015 Oct; 90(10):904-9. PubMed ID: 26149802
[TBL] [Abstract][Full Text] [Related]
52. Monosomal karyotype is not a predictor of dismal outcome in childhood de novo acute myeloid leukemia.
Lee NH; Choi YB; Yi ES; Lee SH; Kim HJ; Lee JW; Sung KW; Koo HH; Yoo KH
Leuk Res; 2016 Nov; 50():57-62. PubMed ID: 27683973
[TBL] [Abstract][Full Text] [Related]
53. Clinical implication and potential function of ARHGEF6 in acute myeloid leukemia: An in vitro study.
Li K; Wang H; Yang C; Li C; Xue B; Zhou J
PLoS One; 2023; 18(4):e0283934. PubMed ID: 37027440
[TBL] [Abstract][Full Text] [Related]
54. [Prognostic significance of early assessment of minimal residual disease in acute myeloid leukemia with mutated NPM1 patients].
Zhao T; Zhu HH; Wang J; Jia JS; Yang SM; Jiang H; Lu J; Chen H; Xu LP; Zhang XH; Jiang B; Ruan GR; Wang DB; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):10-16. PubMed ID: 28219218
[No Abstract] [Full Text] [Related]
55. [Effect of minimal residual disease monitoring by multiparameter flow cytometry pre-conditioning on prognosis of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation].
Lu Y; Wu T; Wang H; Zhao YL; Cao XY; Liu DY; Zhang JP; Xiong M; Zhou JR; Sun RJ; Wei ZJ; Ji SQ; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):118-123. PubMed ID: 28279035
[No Abstract] [Full Text] [Related]
56. [Analysis of clinical outcomes of 63 children with acute monocytic leukemia].
Xu YY; Chen J; Xue HL; Tang JY; Pan C; Jiang H; Ye QD; Luo CY; Zhou M; Gu LJ
Zhonghua Er Ke Za Zhi; 2011 Mar; 49(3):175-80. PubMed ID: 21575364
[TBL] [Abstract][Full Text] [Related]
57. [Effect of NCCN (2015) risk stratification on prognosis of patients with acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation].
Lu Y; Wu T; Zhao YL; Cao XY; Liu DY; Zhang JP; Xiong M; Zhou JR; Sun RJ; Wei ZJ; Wang H; Liu HX; Wang T; Tong CR; Ji SQ; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):44-49. PubMed ID: 28219225
[No Abstract] [Full Text] [Related]
58. High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia.
Zhang H; Zhang N; Wang R; Shao T; Feng Y; Yao Y; Wu Q; Zhu S; Cao J; Zhang H; Li Z; Liu X; Niu M; Xu K
J Transl Med; 2019 Apr; 17(1):106. PubMed ID: 30935386
[TBL] [Abstract][Full Text] [Related]
59. Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant.
Ahn JS; Kim JY; Kim HJ; Kim YK; Lee SS; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Minden MD; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD
Ann Hematol; 2016 Jan; 95(2):301-10. PubMed ID: 26537612
[TBL] [Abstract][Full Text] [Related]
60. Outcome of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with central nervous system involvement.
Aoki J; Ishiyama K; Taniguchi S; Fukuda T; Ohashi K; Ogawa H; Kanamori H; Eto T; Iwato K; Sakamaki H; Morishima Y; Nagamura T; Atsuta Y; Takami A
Biol Blood Marrow Transplant; 2014 Dec; 20(12):2029-33. PubMed ID: 25196856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
